How to Value a Podiatry Practice in 2026

Podiatry is one of the more misunderstood specialties when it comes to practice valuation. Most podiatrists I talk to have heard a single number — "your practice is worth X times collections" — from a colleague or a broker who doesn't specialize in healthcare. The reality is considerably more nuanced. A solo podiatrist doing routine foot care in a leased office sells very differently than a multi-provider group with surgical capability, a diabetic wound care program, and custom orthotics revenue.

Podiatry practices typically sell at 40-65% of annual collections or equivalently 2-4x SDE. Where you fall in that range depends on your patient demographics, service mix, provider count, and the increasing (though still early-stage) interest from private equity in podiatric medicine.

The Diabetic Population: Your Demographic Tailwind

The single most important factor in podiatry practice valuation that most owners underappreciate is the composition of their diabetic patient population. Over 37 million Americans have diabetes, and that number is projected to grow. Every one of them should be seeing a podiatrist regularly — Medicare requires diabetic foot exams, covers therapeutic footwear, and reimburses well for routine diabetic foot care.

A practice where 40-50% of visits are diabetic foot care patients has something extraordinary: a patient base that comes back every 9-12 weeks by medical necessity, with insurance that pays reliably. That's recurring revenue in healthcare terms. Buyers look at your diabetic patient panel and see predictable cash flows stretching years into the future.

Practices with strong diabetic care programs — particularly those with established relationships with endocrinologists and primary care physicians who refer consistently — sell at the top of the collections range. I've seen practices where the diabetic foot care program alone generates $300K-$500K in annual collections with minimal overhead beyond provider time.

Conversely, practices that rely heavily on elective or cosmetic procedures (bunion surgery, cosmetic toenail treatment) face more reimbursement uncertainty and higher patient acquisition costs. That revenue is real, but it's less predictable.

Surgical Capability Changes the Math

Whether your practice has surgical capability — and what kind — is a major valuation swing factor in podiatry.

Office-based procedure roomsfor minor procedures (ingrown toenails, wart excision, soft tissue biopsies) are standard and expected. They don't add significant premium, but their absence would raise questions.

Ambulatory surgery center (ASC) access or ownership is where the value inflection happens. A podiatrist performing reconstructive foot and ankle surgery — bunionectomies, hammertoe corrections, ankle fracture fixation, Charcot reconstruction — generates $400K-$800K+ in collections per provider with significantly higher per-procedure reimbursement. Practices with established ASC block time or ownership stakes in an ASC command premium multiples because the surgical revenue carries higher margins.

Wound care expertisesits at the intersection of surgical capability and the diabetic patient population. Podiatrists running diabetic wound care programs — debridement, wound VAC application, skin grafts — generate high-reimbursement procedure revenue from a patient population that requires ongoing care. If you've built a wound care center or serve as the podiatric lead at a hospital wound care program, that revenue and those referral relationships add material value.

Orthotics Revenue: The Overlooked Profit Center

Custom orthotics represent one of the highest-margin revenue streams in podiatry, and they're often undervalued in practice sales because they're categorized as "ancillary" revenue.

A pair of custom orthotics costs $50-$80 to fabricate from a lab and sells for $300-$500 out of pocket (or is billed at $200-$350 to insurance). At 200-400 pairs per year per provider, that's $60K-$200K in revenue at 70-80% gross margins. This is product revenue with minimal provider time — a quick casting or digital scan during an existing visit.

Practices that have built strong orthotics programs with in-house scanning technology, established lab relationships, and patient education around custom versus over-the-counter devices command premium pricing. Buyers recognize that orthotics revenue is high-margin, doesn't require additional provider appointments, and has a natural replacement cycle (every 2-3 years) that drives repeat purchases.

Provider Count and the Solo Practice Problem

Like most medical practice valuations, the number of providers is a critical factor in podiatry. And the dynamics are particularly challenging for solo practitioners.

Solo podiatry practices face the toughest valuation environment. When you are the only provider, every patient relationship, every surgical outcome, and every referral source is tied to you personally. Buyers know that 20-35% of patients may not return after an ownership transition, and they price accordingly. Solo practices typically sell at 40-50% of collections or 2.0-2.5x SDE.

Two-provider practices are significantly easier to sell and command 50-60% of collections. Having a second podiatrist — even part-time — proves the practice can function with a different provider. It also means the buyer can potentially retain the associate, providing continuity that protects patient retention.

Multi-provider groups (3+ DPMs) with mid-level support are where private equity interest begins. Groups collecting $2M+ with EBITDA margins of 20-30% may attract offers at 5-7x EBITDA from emerging podiatry roll-ups and MSO models. This is still early compared to dental or dermatology consolidation, but the trend is accelerating.

What Hurts Podiatry Practice Value

Medicare-heavy payer mix without volume. Medicare reimbursement for podiatry is adequate but not generous. If 70%+ of your revenue comes from Medicare with low visit volume, margins are compressed. The practices that thrive on Medicare are high-volume operations seeing 30-40+ patients per day per provider — they make it work on throughput, not per-visit reimbursement.

No referral network. Podiatry practices that rely on walk-in traffic and self-referral are less valuable than those with established referral relationships with orthopedists, endocrinologists, primary care physicians, and wound care centers. Documented referral sources that will continue post-sale are a tangible asset.

Aging equipment.Digital X-ray is now standard — if you're still using film, a buyer will deduct $30K-$50K for equipment upgrades. Vascular assessment tools (ABI, pulse volume recording), diagnostic ultrasound, and in-office laser equipment are increasingly expected in modern practices. Major equipment deficiencies get priced into the offer.

Lease risk. Podiatry practices are location-sensitive because patients choose providers partly on convenience. A lease with less than 3 years remaining and no renewal option introduces relocation risk that can reduce offers by 10-20%.

Preparing for a Premium Exit

If you're planning to sell in the next 2-3 years, focus on these high-impact moves:

Grow your diabetic patient panel. Build referral relationships with every endocrinologist and internist in your area. The diabetic foot care patient is the most valuable patient in your practice from a valuation perspective — recurring visits, reliable reimbursement, and medical necessity that survives ownership changes.

Add a provider. Even a part-time associate or a podiatric medical assistant who can handle routine care expands capacity and reduces owner dependency. The jump from solo to two-provider practice can add 15-25% to your valuation.

Build your orthotics program.If you're not maximizing custom orthotics revenue, invest in digital scanning technology, develop patient education materials, and establish a systematic workflow for recommending custom devices to appropriate patients. The ROI on orthotics program development is immediate in operations and compounding in valuation.

Document everything. Referral source tracking, patient retention rates, payer mix analysis, procedure volume by type, and three years of clean financial statements. Buyers who see organized data make faster, higher offers.

The Bottom Line

Podiatry practice valuation is driven by demographics and service mix more than any other factor. The aging and diabetic population is a structural tailwind that makes well-positioned podiatry practices increasingly attractive acquisition targets. Practices that have built around diabetic care, surgical capability, and orthotics revenue — particularly multi-provider groups — are positioned to capture the best exit values in this specialty's history as PE interest continues to grow.